Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients
| Status: | Recruiting |
|---|---|
| Conditions: | Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/12/2017 |
| Start Date: | May 2012 |
| End Date: | January 2018 |
| Contact: | michael levine, md |
| Email: | mdlevine@usc.edu |
| Phone: | 323 226 6667 |
The purpose of this project is to evaluate the case characteristics of patients who receive
intravenous lipid emulsion therapy. Previous literature to date has focused on animal
studies or has been primarily limited to case reports or small case series. This
prospectively collected data set will permit a much more detailed description of the use of
lipid, its potential benefits, and potential harms.
intravenous lipid emulsion therapy. Previous literature to date has focused on animal
studies or has been primarily limited to case reports or small case series. This
prospectively collected data set will permit a much more detailed description of the use of
lipid, its potential benefits, and potential harms.
The purpose of this project is to evaluate the case characteristics of patients who receive
intravenous lipid emulsion therapy. A secondary objective is to determine the mortality in
this critically ill population of individuals.
Previous literature to date has focused on animal studies or has been primarily limited to
case reports or small case series. This prospectively collected data set will permit a much
more detailed description of the use of lipid, its potential benefits, and potential harms.
intravenous lipid emulsion therapy. A secondary objective is to determine the mortality in
this critically ill population of individuals.
Previous literature to date has focused on animal studies or has been primarily limited to
case reports or small case series. This prospectively collected data set will permit a much
more detailed description of the use of lipid, its potential benefits, and potential harms.
Inclusion Criteria:
- receiving intravenous lipid emulsion for treatment of a drug toxicity
- Evaluation of a medical toxicologist as part of the ToxIC registry consortium
Exclusion Criteria:
- not evaluated by a medical toxicologist participating in ToxIC
We found this trial at
2
sites
University of Southern California The University of Southern California is one of the world’s leading...
Click here to add this to my saved trials
Click here to add this to my saved trials